Dengue IgG/IgM
- UID
- IMP/MD/2018/000203_13f95ef30fdeba669c96f2a354f4c8a8_657fb7755842422f52f250fdf71e74bc
- Device class
- Class C
- Brand name
- QDx Instacheck™ AFP
- License holder
- DiaSys Diagnostics India Private Limited
- Approving authority
- CDSCO
- Product information
- QDx Instacheck™ Dengue IgG/IgM is a fluorescence Immunoassay (QDx Instacheck™ AFP) for the qualitative determination of IgG/IgM antibodies against dengue virus in human whole blood/serum/plasma. It is useful as an aid in screening of Dengue virus infection. For in vitro diagnostic use only.,iFOB Neo(QDx Instacheck™ AFP)-QDx Instacheck™ iFOB Neo is a fluorescence Immunoassay (QDx Instacheck™ AFP) for the quantitative determination of hemoglobin in human feces. It is useful as an aid in management and monitoring of colorectal cancer. For in vitro diagnostic use only
Dengue IgG/IgM is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2018/000203_13f95ef30fdeba669c96f2a354f4c8a8_657fb7755842422f52f250fdf71e74bc. This device is marketed under the brand name QDx Instacheck™ AFP. The license holder is DiaSys Diagnostics India Private Limited, and it is classified as Device Class Class C. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.